Gilphex
NDC 58552-336, Guaifenesin, Phenylephrine HCl, tablet, from Gil Pharmaceutical Corp..
- Product NDC
- 58552-336
- Status
- Listed
- Labeler
- Gil Pharmaceutical Corp.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58552-336 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN390 mg/1
- PHENYLEPHRINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58552-336-01 | 58552033601 | 100 TABLET in 1 BOTTLE (58552-336-01) |
| 58552-336-02 | 58552033602 | 2 TABLET in 1 BLISTER PACK (58552-336-02) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58552-336 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58552-336 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58552-336. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.